Key result
Continuation versus discontinuation of antiplatelet therapy in non-cardiac surgical patients is the focus of a Cochrane Review protocol to evaluate bleeding and ischemic events.
Why the study?
Does continuation of antiplatelet therapy compared to discontinuation affect the occurrence of bleeding and ischaemic events in adults undergoing non-cardiac surgery?
Does continuation of antiplatelet therapy compared to discontinuation affect the occurrence of bleeding and ischaemic events in adults undergoing non-cardiac surgery?
This is a protocol for a Cochrane Review evaluating the safety and efficacy of continuing versus discontinuing antiplatelet therapy in adults undergoing non-cardiac surgery.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the effects of continuation versus discontinuation of antiplatelet therapy on the occurrence of bleeding and ischaemic events in non‐cardiac surgical patients.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2017) studied this question. Continuation versus discontinuation of antiplatelet therapy in non-cardiac surgical patients is the focus of a Cochrane Review protocol to evaluate bleeding and ischemic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: